S D Allen

1.7k total citations
53 papers, 1.3k citations indexed

About

S D Allen is a scholar working on Infectious Diseases, Pharmacology and Clinical Biochemistry. According to data from OpenAlex, S D Allen has authored 53 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Infectious Diseases, 17 papers in Pharmacology and 17 papers in Clinical Biochemistry. Recurrent topics in S D Allen's work include Bacterial Identification and Susceptibility Testing (17 papers), Antibiotics Pharmacokinetics and Efficacy (17 papers) and Antibiotic Resistance in Bacteria (13 papers). S D Allen is often cited by papers focused on Bacterial Identification and Susceptibility Testing (17 papers), Antibiotics Pharmacokinetics and Efficacy (17 papers) and Antibiotic Resistance in Bacteria (13 papers). S D Allen collaborates with scholars based in United States, Canada and China. S D Allen's co-authors include V. R. Dowell, A L Barry, E. Gerlach, Peter Fuchs, Louis A. Wilson, Michael A. Pfaller, Janet K. Reynolds, Ronald N. Jones, B. R. Davis and Martin B. Kleiman and has published in prestigious journals such as Journal of Biological Chemistry, Applied and Environmental Microbiology and Clinical Infectious Diseases.

In The Last Decade

S D Allen

53 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S D Allen United States 20 487 393 293 252 218 53 1.3k
Kenneth E. Aldridge United States 18 316 0.6× 348 0.9× 182 0.6× 321 1.3× 216 1.0× 46 1.2k
H.W. Van Landuyt Belgium 21 658 1.4× 459 1.2× 180 0.6× 202 0.8× 144 0.7× 44 1.4k
C. E. Nord Sweden 25 383 0.8× 320 0.8× 400 1.4× 258 1.0× 217 1.0× 74 1.5k
W. Edmund Farrar United States 23 280 0.6× 349 0.9× 302 1.0× 158 0.6× 481 2.2× 78 1.5k
P E Coudron United States 21 447 0.9× 321 0.8× 243 0.8× 376 1.5× 690 3.2× 38 1.5k
I. Braveny Germany 13 679 1.4× 373 0.9× 322 1.1× 483 1.9× 332 1.5× 59 1.4k
Paul D. Ellner United States 23 412 0.8× 371 0.9× 225 0.8× 399 1.6× 132 0.6× 81 1.3k
J. Croizé France 20 219 0.4× 318 0.8× 307 1.0× 78 0.3× 430 2.0× 78 1.2k
J. H. Jorgensen United States 18 404 0.8× 432 1.1× 266 0.9× 220 0.9× 293 1.3× 43 1.3k
E. Yourassowsky Belgium 16 333 0.7× 334 0.8× 196 0.7× 153 0.6× 300 1.4× 170 1.2k

Countries citing papers authored by S D Allen

Since Specialization
Citations

This map shows the geographic impact of S D Allen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S D Allen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S D Allen more than expected).

Fields of papers citing papers by S D Allen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S D Allen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S D Allen. The network helps show where S D Allen may publish in the future.

Co-authorship network of co-authors of S D Allen

This figure shows the co-authorship network connecting the top 25 collaborators of S D Allen. A scholar is included among the top collaborators of S D Allen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S D Allen. S D Allen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Natale, Bryony V., et al.. (2024). Characterizing placental pericytes: Hypoxia and proangiogenic signalling. Placenta. 155. 1–10. 3 indexed citations
2.
Allen, S D, et al.. (2024). Cannabidiol Exposure During Rat Pregnancy Leads to Labyrinth-Specific Vascular Defects in the Placenta and Reduced Fetal Growth. Cannabis and Cannabinoid Research. 9(3). 766–780. 5 indexed citations
3.
Finegold, S M, Yuanyuan Song, Chenli Liu, et al.. (2005). Clostridium clostridioforme: a mixture of three clinically important species. European Journal of Clinical Microbiology & Infectious Diseases. 24(5). 319–324. 59 indexed citations
4.
Barry, A L, Peter Fuchs, C Thornsberry, et al.. (1996). Methods of measuring susceptibility of anaerobic bacteria to trovafloxacin, including quality control parameters. European Journal of Clinical Microbiology & Infectious Diseases. 15(8). 676–678. 3 indexed citations
5.
Barry, A L, Peter Fuchs, S D Allen, et al.. (1996). In-vitro susceptibility of Streptococcus pneumoniae to the d- and l-isomers of ofloxacin: interpretive criteria and quality control limits. Journal of Antimicrobial Chemotherapy. 37(2). 365–369. 18 indexed citations
6.
Allen, S D, et al.. (1995). Cellular Fatty Acid Analysis in the Differentiation of Clostridium Species in the Clinical Microbiology Laboratory. Clinical Infectious Diseases. 20(Supplement_2). S198–S201. 6 indexed citations
7.
Fuchs, Peter, A L Barry, F. C. Tenover, et al.. (1995). Tests for susceptibility of Streptococcus pneumoniae to cefdinir: proposed interpretive criteria and quality control parameters for broth microdilution and disc diffusion methods. Journal of Antimicrobial Chemotherapy. 36(5). 781–786. 4 indexed citations
8.
Barry, A L, Peter Fuchs, Fred C. Tenover, et al.. (1994). Interpretive criteria and quality control for antimicrobial susceptibility tests of levofloxacin. European Journal of Clinical Microbiology & Infectious Diseases. 13(10). 822–826. 7 indexed citations
9.
Barry, A L, Michael A. Pfaller, Peter Fuchs, et al.. (1993). Interpretive criteria and quality control parameters for determining bacterial susceptibility to fosfomycin tromethamine. European Journal of Clinical Microbiology & Infectious Diseases. 12(5). 352–356. 10 indexed citations
10.
Barry, A L, Peter Fuchs, Diane M. Citron, S D Allen, & Hannah M. Wexler. (1993). Methods for testing the susceptibility of anaerobic bacteria to two fluoroquinolone compounds, PD 131628 and clinafloxacin. Journal of Antimicrobial Chemotherapy. 31(6). 893–900. 13 indexed citations
11.
Sader, Hélio S., Ronald N. Jones, S D Allen, et al.. (1993). In VittoComparison Activity ofOPC-17116, a New Fluoroquinolone, Against More Than 5,000 Recent Clinical Isolates from Five Medical Centers. Journal of Chemotherapy. 5(5). 283–288. 14 indexed citations
12.
Murray, Patrick R., S D Allen, M E Erwin, et al.. (1991). Antimicrobial activity of RU29246 (HR916 metabolite) compared with four other oral beta-lactams tested against more than 5000 clinical isolates. European Journal of Clinical Microbiology & Infectious Diseases. 10(9). 776–781. 3 indexed citations
13.
Washington, John A., Ronald N. Jones, S D Allen, et al.. (1991). In vitro comparison of GR69153, a novel catechol-substituted cephalosporin, with ceftazidime and ceftriaxone against 5,203 recent clinical isolates. Antimicrobial Agents and Chemotherapy. 35(7). 1508–1511. 7 indexed citations
14.
Fuchs, Peter, A L Barry, Michael A. Pfaller, S D Allen, & E. Gerlach. (1991). Multicenter evaluation of the in vitro activities of three new quinolones, sparfloxacin, CI-960, and PD 131,628, compared with the activity of ciprofloxacin against 5,252 clinical bacterial isolates. Antimicrobial Agents and Chemotherapy. 35(4). 764–766. 50 indexed citations
15.
Barry, A L, Peter Fuchs, E. Gerlach, et al.. (1990). Multilaboratory Evaluation of an Agar Diffusion Disk Susceptibility Test for Rapidly Growing Anaerobic Bacteria. Clinical Infectious Diseases. 12(Supplement_2). S210–S217. 29 indexed citations
16.
Barry, A L, K E Aldridge, S D Allen, et al.. (1988). In vitro activity of FCE 22101, imipenem, and ceftazidime against over 6,000 bacterial isolates and MIC quality control limits of FCE 22101. European Journal of Clinical Microbiology & Infectious Diseases. 7(6). 794–798. 3 indexed citations
17.
Staneck, Joseph L., et al.. (1985). Automated reading of MIC microdilution trays containing fluorogenic enzyme substrates with the Sensititre Autoreader. Journal of Clinical Microbiology. 22(2). 187–191. 15 indexed citations
18.
Allen, S D, Donald E. Tsai, & Harry Schachter. (1984). Control of glycoprotein synthesis. The in vitro synthesis by hen oviduct membrane preparations of hybrid asparagine-linked oligosaccharides containing 5 mannose residues.. Journal of Biological Chemistry. 259(11). 6984–6990. 34 indexed citations
19.
White, Richard D., et al.. (1979). Comparison of Capillary Ear Blood and Arterial Blood to Validate Capillary Sampling as an Accurate Assay of Blood Gas in Swine. American Journal of Veterinary Research. 40(7). 1022–1024. 2 indexed citations
20.
Allen, S D, et al.. (1978). Use of ethanol for selective isolation of sporeforming microorganisms. Applied and Environmental Microbiology. 35(4). 762–765. 127 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026